Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A
Abstract Background Treatment for haemophilia A has expanded from plasma-derived factor VIII (pdFVIII) and standard half-life (SHL) recombinant FVIII (rFVIII) to extended half-life (EHL) rFVIII and non-factor products that mimic FVIII activity. Objective To determine amounts of clotting factor conce...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , , |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Adis, Springer Healthcare,
2024-08-01T00:00:00Z.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Интернэт
Connect to this object online.3rd Floor Main Library
Зохиогчийн тэмдэгт: |
A1234.567 |
---|---|
Хуулбар 1 | Бэлэн |